Showing 9 of 9 recruiting trials for “Acute biphenotypic leukemia”
A Study of Revumenib and Mezigdomide in People With Leukemia
👨⚕️ Eytan Stein, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Jan 2026View details ↗
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
👨⚕️ Mary-Beth M. Percival, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2022View details ↗
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
👨⚕️ Marie Bleakley, Fred Hutch/University of Washington Cancer Consortium📍 10 sites📅 Started Aug 2019View details ↗
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Personalized NK Cell Therapy in CBT
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →